Delivery Order SPE2DR25D3301-SPE2DR26F23MT
Award Date 3/4/26
Potential Completion Date 3/25/26
Potential Value $38K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $123,064.41 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for supply of Revlimid 10 mg capsules (100-count units), with a final delivery date of March 27, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a single-award IDC valued at up to $999,999,999 through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare...
- The Defense Logistics Agency issued a $22,111.82 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Revlimid 15 mg capsules (21-count). The order is issued under an Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. This vehicle supplies pharmaceutical products and medical supplies globally to support military healthcare programs. The order carries firm fixed pricing with an ultimate completion date of March 20,...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Revlimid 5 mg capsules (100 count), with a ceiling value of $40,287.98. The order is issued under the parent Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 4, 2026, for Revlimid 10 mg capsules (28-count), with a ceiling value of $37,729.77. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply contract valued at $999,999,999.00 through December 2026 that enables AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 6, 2026, with a ceiling value of $6,878.48 for supply of Revlimid 20 mg capsules (21-count). Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 27, 2026. Pricing is firm fixed price, and no set-aside was used. The delivery order is issued under the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract (SPE2DX), a $999.9 million vehicle...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, for Revlimid 10 mg capsules (100-count), with a ceiling value of $205,107.35 under firm fixed-price terms. Place of performance is Conshohocken, PA. Ultimate completion date is March 4, 2026. The order was not set-aside and was issued competitively. The parent vehicle is an Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026,...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for Revlimid 5 mg capsules (28-count), with a ceiling value of $8,965.23 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 25, 2026. No set-aside was used.</p>
- This delivery order, valued at $17,930.46, was awarded on January 8, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (28-count packages). The contract is a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, with a ceiling value of $8,965.23 for supply of Revlimid 5 mg capsule 28-count units.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 5, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order valued at $53,251.31 to AmerisourceBergen Drug Corp for the supply of Revlimid 15 mg capsules (100-count units) on July 24, 2025, with completion expected by August 14, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F23MTDelivery Order
The Defense Logistics Agency issued a $38,352.72 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for Revlimid 10 mg capsules (28-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of March 25, 2026.
Generated 6/2/26, 9:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.4k | 3/3/26 |